Comparing Two Prenatal Supplements for Pregnant Women
Author Information
Author(s): Eric Ahn, Nicholas Pairaudeau, Nicholas Pairaudeau Jr., Yves Cerat, Bernard Couturier, Andre Fortier, Eric Paradis, Gideon Koren
Primary Institution: The University of Toronto
Hypothesis
Is a new micronutrient supplement with lower iron content more tolerable than a high iron supplement for pregnant women?
Conclusion
PregVit®, a supplement with lower iron content, has significantly decreased constipation rates compared to Materna and has similar compliance rates.
Supporting Evidence
- PregVit® was associated with a 30% reduction in constipation rate compared to Materna®.
- Both products demonstrated similar compliance rates.
- Compliance with Materna® was negatively associated with the severity of nausea and vomiting of pregnancy.
Takeaway
PregVit® is easier for pregnant women to take because it causes less constipation than another supplement with more iron.
Methodology
Randomized, crossover open labeled study.
Potential Biases
Participants who dropped out did not differ from those who completed the study.
Limitations
High dropout rate and the study's design may improve compliance artificially.
Participant Demographics
Pregnant women aged 18 to 45.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website